TB epidemiological studies in infants and adolescents for TB vaccine trials
Dr. Nduba is a medical officer and PhD student (Epidemiology) at the Academic Medical Center, University of Amsterdam. He is also the principal investigator for a multi center phase IIb TB vaccine trial (Aeras 402) in infants of which Kenya is one of 4 countries participating in this trial. He has been at KEMRI/CDC for 5 years where his work at the TB Research Branch includes developing tuberculosis epidemiological capacity to conduct phase II and III TB vaccine trials in adolescents and infants. Previously he was involved in a multicenter trial examining the efficacy of suppressing genital herpes with acyclovir to prevent HIV transmission among HIV discordant couples at KEMRI.